Comparing the efficacy and cost of cilnidipine with amlodipine in the management of hypertension at a single tertiary care hospital
Author(s): G Satyanarayana Raju and Jervin Mavo M
Abstract: Background and Objective: High blood pressure, which is now described as a systolic blood pressure over 140 mm Hg and a diastolic blood pressure over 90 mm Hg, is the main cause of death from heart disease, according to the World Health Organization. The goal of this study was to compare how cost-effective Cilnidipine and Amlodipine are for treating high blood pressure in major healthcare facilities.
Materials and Methods: The current study took place over 12 months, from January 2018 to December 2018, at Sree Balaji Medical College and hospital in Chennai, India. It was led by the Department of Pharmacology and the Department of Medicine and looked at newly diagnosed hypertensive patients who went to the outpatient department. It was found that 80 people, of either gender and between the ages of 18 and 60, had mild to moderate high blood pressure. We chose at random 40 patients who were given Cilnidipine and 40 patients who were given Amlodipine.
Results: The 80 people who took part in our study were split evenly between men and women. There were more people in both groups whose blood pressure was slightly higher than normal. When looking at the adverse drug reactions side effects side by side, Amlodipine has more of them than Cilnidipine. We get information about how much the study drug costs each patient on a regular basis and how much their systolic and diastolic blood pressure drops on average in two groups. Our data shows that compared to the Amlodipine group, the Cilnidipine group had fewer adverse drug reactions and no cases of leg edema.
Conclusions: Our study shows that Cilnidipine may be a better value for money than Amlodipine, since the people who took Cilnidipine had a lot of fewer adverse drug reactions for the same price.
Pages: 120-122 | Views: 43 | Downloads: 15Download Full Article: Click Here
How to cite this article:
G Satyanarayana Raju, Jervin Mavo M. Comparing the efficacy and cost of cilnidipine with amlodipine in the management of hypertension at a single tertiary care hospital. Int J Adv Res Med 2019;1(1):120-122.
